Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean benzophenone-3 3 3 and hydroquinone?
Displaying drugs 15501 - 15525 of 15867 in total

Pegtarviliase

Pegtarviliase is under investigation in clinical trial NCT05154890 (A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency).
Investigational

Mivelsiran

Mivelsiran is under investigation in clinical trial NCT06393712 (A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy).
Investigational

Imdusiran

Imdusiran is under investigation in clinical trial NCT06245291 (Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection).
Investigational

CRA_10991

Experimental

Xylose-derived lactam oxime

Experimental

D-gluconhydroximo-1,5-lactam

Experimental

Carbazole Butanoic Acid

Experimental

Indole

Experimental

Hydronidone

Hydronidone has antifibrotic activity.
Investigational

5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole

Experimental

2-Nonyl-4-quinolinol 1-oxide

Experimental

OSI-027

OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma.
Investigational

Iopydol

Experimental

Obidoxime

Experimental

2-amino-8-methyl-4(1H)-quinazolinone

Experimental

4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid

Experimental

Mevastatin

Mevastatin or compactin is a cholesterol-lowering agent isolated from Penicillium citinium. It was the first discovered agent belonging to the class of cholesterol-lowering medications known as statins. During a search for antibiotic compounds produced by fungi in 1971, Akira Endo at Sankyo Co. (Japan) discovered a class of compounds that...
Experimental
Matched Description: … The compound was proposed to bind to the reductase enzyme and was named compactin. …

6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE

Experimental

4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one

Experimental

Piribedil

Piribedil has been investigated in Parkinson's Disease.
Investigational

Dipraglurant

Dipraglurant has been used in trials studying the treatment of Parkinson's Disease. It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).
Investigational

RPI-78M

RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).
Investigational
Matched Description: … neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and …

IPH 1101

IPH 1101 is a chemically-synthesized structural analog of non-conventional bacterial phosphoantigens which specifically activate the Vγ9Vδ2 T cell subset. IPH 1101 is the most advanced drug candidate of the γδ T cell platform
Investigational

Transcrocetinate

Vitamin A-analog that increases diffusivity of oxygen in aqueous solutions, including plasma.
Investigational

CX157

CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous MAO-A inhibitors of this class.
Investigational
Matched Description: … dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and …
Displaying drugs 15501 - 15525 of 15867 in total